| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.01 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.22 | 0.02 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.02 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.11 | 0.03 |